Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
Malluche, H H
Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients. [electronic resource] - Contributions to nephrology 1980 - 98-104 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0302-5144
10.1159/000403277 doi
Adult
Aged
Alkaline Phosphatase--blood
Calcium--blood
Dihydroxycholecalciferols--therapeutic use
Female
Humans
Hydroxycholecalciferols--therapeutic use
Male
Middle Aged
Osteomalacia--blood
Parathyroid Hormone--blood
Phosphates--blood
Renal Dialysis
Uremia--blood
Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients. [electronic resource] - Contributions to nephrology 1980 - 98-104 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0302-5144
10.1159/000403277 doi
Adult
Aged
Alkaline Phosphatase--blood
Calcium--blood
Dihydroxycholecalciferols--therapeutic use
Female
Humans
Hydroxycholecalciferols--therapeutic use
Male
Middle Aged
Osteomalacia--blood
Parathyroid Hormone--blood
Phosphates--blood
Renal Dialysis
Uremia--blood